Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(7%)
Results Posted
27%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_4
3
21%
Ph not_applicable
7
50%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
unknown1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 43 (27.3%)
N/A7 (63.6%)

Trials by Status

unknown17%
completed1179%
recruiting17%
terminated17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
PROCEDURE
Total Trials
14